4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0001140361-16-049547
Options or other derivatives
- Chief Medical Officer acquired 598,734 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Benaim Ely · Chief Medical Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-01-28 | Grant or award : show line 1 in the form Stock Option (right to buy) | +98,734 | $0.35 | 2026-01-28 | 98,734 | 98,734 | D |
| 2016-01-28 | Grant or award : show line 2 in the form Stock Option (right to buy) | +500,000 | $0.35 | 2026-01-28 | 500,000 | 500,000 | D |
Loading xslF345X03/doc1.xml…